Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists

Details for Australian Patent Application No. 2008232265 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Sturino, Claudio; Farand, Julie; Burch, Jason; Han, Yongxin

Agent Spruson & Ferguson

Pub. Number AU-A-2008232265

PCT Pub. Number WO2008/116304

Priority 60/920,018 26.03.07 US

Filing date 25 March 2008

Wipo publication date 2 October 2008

International Classifications

C07D 209/64 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4035 (2006.01)

A61K 31/4745 (2006.01)

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/116304 Priority application(s): WO2008/116304

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232269-Quinolone and tetrahydroquinoline and related compounds having NOS inhibitory activity

2008232262-Fluorinated derivatives of deferiprone